Idexx Laboratories (IDXX) Net Cash Flow Growth (3y) (2012 - 2026)
Idexx Laboratories (IDXX) Net Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 58.74% |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | -43.12% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | -29.30% |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | 41.14% |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | 27.97% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | 29.81% |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | -40.43% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | -38.01% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 89.23% |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 138.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -29.30% |
| Mar 31, 2026 | 144.76% |
| Dec 31, 2025 | -79.19% |
| Sep 30, 2025 | 90.31% |
| Jun 30, 2025 | 44.98% |
| Mar 31, 2025 | -59.45% |
| Dec 31, 2024 | -370.15% |
| Sep 30, 2024 | -5.29% |
| Jun 30, 2024 | 26.88% |
| Mar 31, 2024 | -20.70% |
| Dec 31, 2023 | -16.73% |
| Sep 30, 2023 | 42.63% |
| Jun 30, 2023 | -0.37% |
| Mar 31, 2023 | 30.00% |
| Dec 31, 2022 | 35.76% |
| Sep 30, 2022 | -23.33% |
| Jun 30, 2022 | -132.32% |
| Mar 31, 2022 | 122.30% |
| Dec 31, 2021 | 26.09% |
| Sep 30, 2021 | -44.68% |